Circle Pharma近日宣布完成新一轮融资。此轮融资由Column Group领投，Nextech Invest与Ra Capital Management共同参与。值得注意的是，礼来公司（Eli Lilly and Co）也以战略投资者的身份加入其中。
这一资本动作引发市场广泛关注。多方资本汇聚，既体现了投资界对Circle Pharma前景的认可，也凸显了制药巨头礼来在创新疗法领域的布局意图。具体融资金额尚未披露，但参与的机构阵容已然透露出足够的分量。
从投资方结构来看，既有深耕生物医药的专业风投，也有全球领先的药企巨头，这种组合往往意味着更深层的战略协同可能性。Circle Pharma的研发管线或将成为这些资本力量交汇的焦点所在。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.